BSL-3 Mobile Biocontainment Laboratory for Vaccine Development Research
Currently in use for vaccine development this BSL-3 laboratory was delivered in November 2020. It is a self contained mobile unit with engineering controls that protect personnel while isolating infectious agents.
Size: 450 sq. ft
Layout configurations: 3 room
Facilities/Equipment: 2 class II type A2 BSC’s computer workstation laboratory sterilizer incubator
Features: Low wall returns, HEPA air filtration, seamless primary walls, negative pressure work areas
Additional services provided: Commissioning, 3rd party validation, collaboration with CDC for licensing
The challenge was to provide a freestanding Covid-19 research facility on an accelerated timeline built for continuous use in the cold climate of the northeast United States without a shell building.
Our client required a fit for purpose BSL-3 mobile facility in the midst of a global pandemic for infectious organism research. The work involved serious or potentially lethal disease as a result of exposure through inhalation. The biological research involved infectious organisms that were cultured, incubated, and isolated from other site infrastructure creating a truly sealed environment.
Commissioning this facility for use with the CDC was challenging in the midst of a global pandemic however, our experienced commissioning and biosafety officer certification was leveraged for CDC licensing which happened in record time for both the client and the CDC.
This facility was built on Germfree’s proven mobile biocontainment lab platform, click here to learn more about our Mobile Biocontainment Labs.